Group 1: A-Share Market Overview - On December 12, A-share market indices showed mixed performance, with the Shanghai Composite Index slightly down by 0.04%, while the Shenzhen Component Index rose by 0.57% and the ChiNext Index increased by 0.6% [2] - The sectors that performed well included nuclear fusion, nuclear power, ultra-high voltage, and superconducting concepts, with their respective indices rising over 3% [2] Group 2: Nuclear Power Sector - The nuclear power sector experienced a significant increase, with the concept index rising by 3.17%, and over 4 billion yuan of main funds flowing into the sector [3] - Key stocks such as Sun Cable, Zhongchao Holdings, and Changcheng Electric reached their daily limit, with Sun Cable seeing over 116 million shares bought at a total of over 1.2 billion yuan [3] - Recent achievements in China's nuclear power projects include the successful grid connection of the world's largest "Hualong One" nuclear power base and the initiation of construction at the Shandong Zhaoyuan nuclear power base [3] Group 3: Cosmetics Industry Developments - The National Medical Products Administration (NMPA) released a three-year action plan aimed at enhancing the production quality management system for cosmetics from 2026 to 2028, encouraging innovation in quality management and the adoption of intelligent production methods [5] - As of now, China has transitioned from a major cosmetics producer to a strong player in the industry, with over 230,000 registered products and a market share of domestic cosmetics exceeding 55.2% [6] - The cosmetics market in China is projected to maintain a trillion-yuan scale in 2024, with over 5,700 companies in the sector [6] Group 4: Financial Performance of Cosmetics Companies - Among the 47 A-share companies involved in the cosmetics industry, 18 reported a year-on-year increase in net profit for the first three quarters, with notable growth from companies like Fujilai and Qingsong Co., with increases of 430.16% and 246.98% respectively [7][8] - A total of 12 companies saw an increase in R&D expenses, with Shiang Technology reporting a record high R&D expenditure of 29.13 million yuan for the first three quarters [8] - Financing activity has been robust, with 16 stocks receiving net inflows since December, led by companies like Lihua Kechuang and Aimeike [8]

Market Overview - On December 12, A-share market indices showed mixed performance, with the Shanghai Composite Index slightly down by 0.04%, while the Shenzhen Component Index and the ChiNext Index rose by 0.57% and 0.6% respectively [1] - Sectors such as nuclear fusion, nuclear power, ultra-high voltage, and superconductors saw significant gains, with concept indices rising over 3% [1] Nuclear Power Sector - The nuclear power sector experienced a strong rally, with the concept index increasing by 3.17%. Key stocks like Sun Cable, Zhongchao Holdings, Changcheng Electric, and Guoji Heavy Industry reached their daily limit up [2] - Over 4 billion yuan of institutional funds flowed into the nuclear power sector [2] - China Western Electric also surged to its daily limit, with a buy order volume of 1.2577 million shares and over 1.1 billion yuan in buy orders [4] - Recent achievements in China's nuclear power projects include the successful grid connection of the world's largest "Hualong One" nuclear power base and the initiation of construction at the Shandong Zhaoyuan nuclear power base [4] - Huajin Securities reports that the advantages of nuclear power are becoming more evident as the grid faces increasing pressure from intermittent renewable energy sources [4] Cosmetics Industry - The National Medical Products Administration released a three-year action plan (2026-2028) aimed at enhancing the production quality management system for cosmetics companies [5] - The plan encourages the use of intelligent and diversified production methods to improve quality and efficiency, and supports the development of a standardized, intelligent, and internationalized cosmetics industry [5] - The Chinese cosmetics market is projected to maintain a scale exceeding 1 trillion yuan in 2024, with over 5,700 companies in the sector [6] - The competition among cosmetics brands is intensifying, with domestic brands making significant advancements in R&D and market strategies [6] - A total of 47 A-share companies are involved in the cosmetics industry, with notable stock performances including Liren Lizhuang, which rose by 4.75% [7] - Among 18 companies reporting profit growth, Fujilai and Qingsong Co. showed significant increases in net profit, with growth rates of 430.16% and 246.98% respectively [7] - R&D expenditures are increasing among profitable companies, with 12 out of 18 companies reporting growth in R&D spending [8]

Core Viewpoint - The company reported significant growth in its packaging and printing business in the first half of the year, while the cosmetics segment's revenue share did not increase further, and gross margins remained stable [1] Group 1: Business Performance - The packaging and printing business experienced substantial year-on-year revenue growth [1] - The cosmetics business's contribution to total revenue did not see further improvement [1] - Gross margin levels were maintained without significant fluctuations [1] Group 2: Strategic Initiatives - The company is enhancing its cosmetics OEM business by executing a defined business development strategy and focusing on building strategic partnerships with key clients, particularly ODM customers [1] - A rolling forecast system and real-time order shipment monitoring system were established to improve business precision and service quality [1] Group 3: Product Development - The company has identified key product development strategies based on market research and competitive analysis, focusing on skincare, wax-based, and powder categories [1] - New flagship products such as water light cream, multi-use potato mud cream, and blush cream were successfully developed [1] Group 4: Operational Strategy - The company's main operational focus is on the principles of "increasing revenue" and "cost-saving" to achieve continuous business expansion and profit improvement [1]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [12]. Core Insights - The company achieved a revenue of 515 million yuan in H1 2025, representing a year-on-year growth of 43.76%, and a net profit attributable to shareholders of 78.32 million yuan, up 432.14% year-on-year [1]. - The packaging segment generated 479 million yuan in revenue, a 52.85% increase year-on-year, driven by market expansion and significant growth in the packaging printing business [2]. - The cosmetics segment reported a revenue of 42.29 million yuan, down 13.52% year-on-year [2]. - The company has signed strategic cooperation agreements with several new clients, including major cosmetics and health companies, and has successfully developed new products in its subsidiaries [2]. Financial Summary - The company's gross margin improved to 28.40% in H1 2025, an increase of 7.37 percentage points year-on-year [3]. - Revenue projections for 2025-2027 are estimated at 1.117 billion yuan, 1.426 billion yuan, and 1.769 billion yuan, respectively, with net profits expected to be 152 million yuan, 204 million yuan, and 267 million yuan [3][4]. - The report indicates a significant increase in earnings per share, projected to rise from 0.31 yuan in 2024 to 0.88 yuan in 2027 [4]. Market Data - As of September 4, 2025, the company's closing price was 17.63 yuan, with a 12-month price range of 13.28 to 37.43 yuan [5]. - The total market capitalization is approximately 5.33 billion yuan [5]. Performance Metrics - The company has shown strong absolute returns of 80% over the past 12 months, outperforming the market [8]. - The projected price-to-earnings ratio is expected to decrease from 83.39 in 2024 to 19.97 in 2027, indicating improved valuation over time [4].